Biologic therapy for refractory pemphigoid gestationis: An evidence-based systematic review by Siddhartha Sood, HBSc, Jensen Yeung, MD, Asfandyar Mufti, MD

Connect to this object online.

Squamous cell carcinoma arising within discoid lupus erythematous lesions: A systematic review by Asfandyar Mufti, MD, Muskaan Sachdeva, BHSc, Khalad Maliyar, BA, R. Gary Sibbald, FRCPC

Connect to this object online.

COVID-19 and wound care: A Canadian perspective by Asfandyar Mufti, MD, Muskaan Sachdeva, BHSc, Khalad Maliyar, BA, R. Gary Sibbald, MD, FRCPC

Connect to this object online.

Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic reviewCapsule Summary by Yuliya Lytvyn, PhD, Katherine McDonald, MD, Asfandyar Mufti, MD, Jennifer Beecker, MD, CCFP (EM)

Connect to this object online.

Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter study by Yuliya Lytvyn, PhD, Hiba Zaaroura, MD, Asfandyar Mufti, MD, Shaikhah AlAbdulrazzaq, MD, Jensen Yeung, MD, FRCPC

Connect to this object online.

Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review by Abrahim Abduelmula, BScN, Asfandyar Mufti, MD, Derrick HY. Chong, BSc, Siddhartha Sood, HBSc, Muskaan Sachdeva, MD, Jensen Yeung, MD

Connect to this object online.

Treatment outcomes in patients with papuloerythroderma of Ofuji: A systematic review by Asfandyar Mufti, MD, Yuliya Lytvyn, PhD, Abrahim Abduelmula, BScN, Patrick Kim, BHSc, Muskaan Sachdeva, BHSc, Jensen Yeung, MD, FRCPC

Connect to this object online.

Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based review by Abrahim Abduelmula, BScN, Asfandyar Mufti, MD, Derrick H.Y. Chong, BSc, Siddhartha Sood, HBSc, Vimal H. Prajapati, MD, Jensen Yeung, MD

Connect to this object online.

Treatment outcomes of biologics and small molecules for chronic hand eczema: An evidence-based systematic review by Siddhartha Sood, HBSc, Edgar Akuffo-Addo, MHA, Jorge R. Georgakopoulos, MD, Asfandyar Mufti, MD, FRCPC, Khalad Maliyar, MD, Jensen Yeung, MD, FRCPC

Connect to this object online.

A systematic review of vitiligo onset and exacerbation in patients receiving biologic therapy by Muskaan Sachdeva, BHSc, Asfandyar Mufti, MD, Nadia Kashetsky, MSc, Jorge R. Georgakopoulos, MD, Sheida Naderi-Azad, BSc, Jennifer Salsberg, MD, FRCPC, Jensen Yeung, MD, FRCPC

Connect to this object online.

Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literatureCapsule Summary by Asfandyar Mufti, MD, Sara Mirali, PhD, Abrahim Abduelmula, BScN, Katherine Ann McDonald, MD, Shaikhah Alabdulrazzaq, BMBCh, Muskaan Sachdeva, BHSc, Jensen Yeung, MD, FRCPC

Connect to this object online.

Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review by Siddhartha Sood, HBSc, Ahmed Bagit, BSc, Martin Heung, Khalad Maliyar, MD, Abrahim Abduelmula, MD, Muskaan Sachdeva, MD, Jorge R. Georgakopoulos, MD, Asfandyar Mufti, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD

Connect to this object online.

Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the... by Ahmed Bagit, BSc, Khalad Maliyar, MD, Jorge R. Georgakopoulos, MD, Brian Rankin, BSc, Alexander Rimke, MSc, Asfandyar Mufti, MD, Heather Le, CRC, Ronald Vender, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD

Connect to this object online.

Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study by Yuliya Lytvyn, PhD, Asfandyar Mufti, MD, Hiba Zaaroura, MD, Muskaan Sachdeva, BHSc, Justin D. Lu, MSc, Brian D. Rankin, PhD, Vimal H. Prajapati, MD, Ronald Vender, MD, Jensen Yeung, MD, FRCPC

Connect to this object online.